Does Provision of Point of Care CD4 Technology and Early Knowledge of CD4 Levels Affect Early Initiation and Retention on Anti-retroviral Treatment (ART) in HIV Positive Pregnant Women in the Context of Option B+ for PMTCT? (E4E)

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2014 by WHO, Department of Maternal, Newborn, Child and Adolescent Health
Sponsor:
Collaborators:
Canadian International Development Agency
Netherlands: Ministry of Health, Welfare and Sports
Information provided by (Responsible Party):
WHO, Department of Maternal, Newborn, Child and Adolescent Health
ClinicalTrials.gov Identifier:
NCT02070900
First received: February 18, 2014
Last updated: February 20, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2016
  Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)
No publications provided by WHO, Department of Maternal, Newborn, Child and Adolescent Health

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):